Literature DB >> 23620592

Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3.

Guo-Zhong Tao1, Nadja Lehwald, Kyu Yun Jang, Joy Baek, Baohui Xu, M Bishr Omary, Karl G Sylvester.   

Abstract

Numerous liver diseases are associated with extensive oxidative tissue damage. It is well established that Wnt/β-catenin signaling directs multiple hepatocellular processes, including development, proliferation, regeneration, nutrient homeostasis, and carcinogenesis. It remains unexplored whether Wnt/β-catenin signaling provides hepatocyte protection against hepatotoxin-induced apoptosis. Conditional, liver-specific β-catenin knockdown (KD) mice and their wild-type littermates were challenged by feeding with a hepatotoxin 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet to induce chronic oxidative liver injury. Following the DDC diet, mice with β-catenin-deficient hepatocytes demonstrate increased liver injury, indicating an important role of β-catenin signaling for liver protection against oxidative stress. This finding was further confirmed in AML12 hepatocytes with β-catenin signaling manipulation in vitro using paraquat, a known oxidative stress inducer. Immunofluorescence staining revealed an intense nuclear FoxO3 staining in β-catenin-deficient livers, suggesting active FoxO3 signaling in response to DDC-induced liver injury when compared with wild-type controls. Consistently, FoxO3 target genes p27 and Bim were significantly induced in β-catenin KD livers. Conversely, SGK1, a β-catenin target gene, was significantly impaired in β-catenin KD hepatocytes that failed to inactivate FoxO3. Furthermore, shRNA-mediated deletion of FoxO3 increased hepatocyte resistance to oxidative stress-induced apoptosis, confirming a proapoptotic role of FoxO3 in the stressed liver. Our findings suggest that Wnt/β-catenin signaling is required for hepatocyte protection against oxidative stress-induced apoptosis. The inhibition of FoxO through its phosphorylation by β-catenin-induced SGK1 expression reduces the apoptotic function of FoxO3, resulting in increased hepatocyte survival. These findings have relevance for future therapies directed at hepatocyte protection, regeneration, and anti-cancer treatment.

Entities:  

Keywords:  Cytoprotection; Foxo; Liver Injury; Oxidative Stress; Reactive Oxygen Species (ROS); Wnt Signaling

Mesh:

Substances:

Year:  2013        PMID: 23620592      PMCID: PMC3682526          DOI: 10.1074/jbc.M112.445965

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1.

Authors:  I Shin; A V Bakin; U Rodeck; A Brunet; C L Arteaga
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

2.  Palmitate-induced apoptosis can occur through a ceramide-independent pathway.

Authors:  L L Listenberger; D S Ory; J E Schaffer
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

Review 3.  Cell cycle and death control: long live Forkheads.

Authors:  Boudewijn M T Burgering; Geert J P L Kops
Journal:  Trends Biochem Sci       Date:  2002-07       Impact factor: 13.807

4.  Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells.

Authors:  Meredith L L Leong; Anita C Maiyar; Brian Kim; Bridget A O'Keeffe; Gary L Firestone
Journal:  J Biol Chem       Date:  2002-12-16       Impact factor: 5.157

5.  Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.

Authors:  Xinping Tan; Udayan Apte; Amanda Micsenyi; Emorphia Kotsagrelos; Jian-Hua Luo; Sarangarajan Ranganathan; Dulabh K Monga; Aaron Bell; George K Michalopoulos; Satdarshan P S Monga
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

6.  The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2.

Authors:  Marie Stahl; Pascale F Dijkers; Geert J P L Kops; Susanne M A Lens; Paul J Coffer; Boudewijn M T Burgering; René H Medema
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

7.  Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.

Authors:  F T Kolligs; G Hu; C V Dang; E R Fearon
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 8.  Alcohol and oxidative liver injury.

Authors:  Aparajita Dey; Arthur I Cederbaum
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 9.  Oxidative stress in viral and alcoholic hepatitis.

Authors:  Carmela Loguercio; Alessandro Federico
Journal:  Free Radic Biol Med       Date:  2003-01-01       Impact factor: 7.376

10.  Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation.

Authors:  Natasha T Snider; Sujith V W Weerasinghe; Amika Singla; Jessica M Leonard; Shinichiro Hanada; Philip C Andrews; Anna S Lok; M Bishr Omary
Journal:  J Cell Biol       Date:  2011-10-17       Impact factor: 10.539

View more
  45 in total

1.  Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Authors:  Sarah A Comerford; Elizabeth A Hinnant; Yidong Chen; Hima Bansal; Shawn Klapproth; Dinesh Rakheja; Milton J Finegold; Dolores Lopez-Terrada; Kathryn A O'Donnell; Gail E Tomlinson; Robert E Hammer
Journal:  JCI Insight       Date:  2016-10-06

2.  CaMKII represses transcriptionally active β-catenin to mediate acute ethanol neurodegeneration and can phosphorylate β-catenin.

Authors:  George R Flentke; Ana Garic; Marcos Hernandez; Susan M Smith
Journal:  J Neurochem       Date:  2013-10-24       Impact factor: 5.372

Review 3.  Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.

Authors:  Mansi A Parasramka; Sayantan Maji; Akiko Matsuda; Irene K Yan; Tushar Patel
Journal:  Pharmacol Ther       Date:  2016-03-22       Impact factor: 12.310

Review 4.  Dysregulation of redox pathways in liver fibrosis.

Authors:  Natalie J Torok
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

5.  Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis.

Authors:  Moreshwar S Desai; Zeena Eblimit; Sundararajah Thevananther; Astrid Kosters; David D Moore; Daniel J Penny; Saul J Karpen
Journal:  Liver Int       Date:  2014-01-12       Impact factor: 5.828

6.  Hepatoprotective role of berberine against paraquat-induced liver toxicity in rat.

Authors:  Aziz Eftekhari; Amir Hasanzadeh; Rovshan Khalilov; Hasan Hosainzadegan; Elham Ahmadian; Mohammad Ali Eghbal
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-16       Impact factor: 4.223

7.  NADPH Oxidases in Chronic Liver Diseases.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Adv Hepatol       Date:  2014-11-30

Review 8.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

9.  Loss of hepatocyte β-catenin protects mice from experimental porphyria-associated liver injury.

Authors:  Harvinder Saggi; Dhiman Maitra; An Jiang; Rong Zhang; Pengcheng Wang; Pamela Cornuet; Sucha Singh; Joseph Locker; Xiaochao Ma; Harry Dailey; Marc Abrams; M Bishr Omary; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  J Hepatol       Date:  2018-10-01       Impact factor: 25.083

Review 10.  FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.